3rd Circ. Sends Fosamax Suits To District Court
The Third Circuit on Monday sent hundreds of suits over the fracture risks of Merck's osteoporosis drug Fosamax back to district court to decide if the claims are barred by federal...To view the full article, register now.
Already a subscriber? Click here to view full article